Fentanyl-related Compounds and Derivatives: Current Status and Future Prospects for Pharmaceutical Applications

Overview

Journal Future Med Chem

Specialties Chemistry
Pharmacy

Date 2014 Mar 19

PMID 24635521

Citations 72

Authors

Ruben S Vardanyan

Victor J Hruby

Affiliations

Soon will be listed here.

Abstract

Fentanyl and its analogs have been mainstays for the treatment of severe to moderate pain for many years. In this review, we outline the structural and corresponding synthetic strategies that have been used to understand the structure-biological activity relationship in fentanyl-related compounds and derivatives and their biological activity profiles. We discuss how changes in the scaffold structure can change biological and pharmacological activities. Finally, recent efforts to design and synthesize novel multivalent ligands that act as mu and delta opioid receptors and NK-1 receptors are discussed.

Citing Articles

Discovery of Novel pH-Sensitive μ-Opioid Receptor Agonists as Potent Analgesics with Reduced Side Effects.

Wang Z, Li Z, Han X, Dong J, Yin M, Song J ACS Med Chem Lett. 2025; 16(2):285-293.

PMID: 39967625 PMC: 11831565. DOI: 10.1021/acsmedchemlett.4c00529.

The Rise of Fentanyl: Molecular Aspects and Forensic Investigations.

Barletta C, Di Natale V, Esposito M, Chisari M, Cocimano G, Di Mauro L Int J Mol Sci. 2025; 26(2).

PMID: 39859160 PMC: 11765396. DOI: 10.3390/ijms26020444.

Development and preclinical testing of a naloxone prodrug depot for extended protection against opioid overdose.

Aldawod H, Patel A, Emara R, Liang D, Ho J, Amin T Nat Commun. 2025; 16(1):686.

PMID: 39848946 PMC: 11758388. DOI: 10.1038/s41467-025-55945-4.

Evaluation of Subetadex-α-methyl, a Polyanionic Cyclodextrin Scaffold, as a Medical Countermeasure against Fentanyl and Related Opioids.

Malfatti M, Enright H, McCloy S, Ubick E, Kuhn E, Subramanian A ACS Cent Sci. 2024; 10(12):2200-2212.

PMID: 39735318 PMC: 11672541. DOI: 10.1021/acscentsci.4c00682.

Efficacy and safety of a generic remifentanil formulation versus fentanyl and Ultiva during general anaesthesia: A phase III, prospective, multi-centric, observer-blind, randomised controlled trial.

Hemantkumar I, Swain A, Mishra M, Singh S, Gurudatt C, Giridhar J Indian J Anaesth. 2024; 68(11):985-995.

PMID: 39659536 PMC: 11626876. DOI: 10.4103/ija.ija_289_24.

References

Rozenfeld R, Devi L . Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. FASEB J. 2007; 21(10):2455-65. PMC: 3131006. DOI: 10.1096/fj.06-7793com. View

Hruby V, Porreca F, Yamamura H, Tollin G, Agnes R, Lee Y . New paradigms and tools in drug design for pain and addiction. AAPS J. 2006; 8(3):E450-60. PMC: 1764851. DOI: 10.1208/aapsj080353. View

Nichol G, Vardanyan R, Hruby V . Synthesis and Crystallographic Study of '-(1-benzylpiperidin-4-yl)acetohydrazide. J Chem Crystallogr. 2014; 40(11):961-964. PMC: 4260262. DOI: 10.1007/s10870-010-9771-1. View

Dietis N, Guerrini R, Calo G, Salvadori S, Rowbotham D, Lambert D . Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. Br J Anaesth. 2009; 103(1):38-49. DOI: 10.1093/bja/aep129. View

WRIGHT Jr W, HARDY Jr R . SYNTHETIC ANALGESICS. IV. SYNTHESIS OF ENANTIOMERS OF BASIC ANILIDES CONTAINING THE PHENALKYL MOIETY. J Med Chem. 1963; 6:128-30. DOI: 10.1021/jm00338a009. View

Vuckovic S, Prostran M, Ivanovic M, Ristovic Z, Stojanovic R . Antinociceptive activity of the novel fentanyl analogue iso-carfentanil in rats. Jpn J Pharmacol. 2000; 84(2):188-95. DOI: 10.1254/jjp.84.188. View

Jeal W, Benfield P . Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control. Drugs. 1997; 53(1):109-38. DOI: 10.2165/00003495-199753010-00011. View

Finney Z, RILEY T . 4-Anilidopiperidine analgesics. 3. 1-Substituted 4-(propananilido)perhydroazepines as ring-expanded analogues. J Med Chem. 1980; 23(8):895-9. DOI: 10.1021/jm00182a016. View

Loew G . Development of a conformational search strategy for flexible ligands: a study of the potent mu-selective opioid analgesic fentanyl. J Comput Aided Mol Des. 1991; 5(4):335-56. DOI: 10.1007/BF00126667. View

10.

Massey J . Stop the pain: fentanyl is a viable alternative to morphine. JEMS. 2011; 36(8):54-7. DOI: 10.1016/S0197-2510(11)70206-6. View

11.

Morphy R, Rankovic Z . Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005; 48(21):6523-43. DOI: 10.1021/jm058225d. View

12.

Davis M . Fentanyl for breakthrough pain: a systematic review. Expert Rev Neurother. 2011; 11(8):1197-216. DOI: 10.1586/ern.11.63. View

13.

Taylor D . Fentanyl buccal tablet: rapid relief from breakthrough pain. Expert Opin Pharmacother. 2007; 8(17):3043-51. DOI: 10.1517/14656566.8.17.3043. View

14.

Woodcock J, Witter J, Dionne R . Stimulating the development of mechanism-based, individualized pain therapies. Nat Rev Drug Discov. 2007; 6(9):703-10. DOI: 10.1038/nrd2335. View

15.

Peng P, Sandler A . A review of the use of fentanyl analgesia in the management of acute pain in adults. Anesthesiology. 1999; 90(2):576-99. DOI: 10.1097/00000542-199902000-00034. View

16.

Lee Y, Kulkarani V, Cowell S, Ma S, Davis P, Hanlon K . Development of potent μ and δ opioid agonists with high lipophilicity. J Med Chem. 2010; 54(1):382-6. PMC: 3136578. DOI: 10.1021/jm100982d. View

17.

Darwish M, Messina J . Clinical pharmacology of fentanyl buccal tablet for the treatment of breakthrough pain. Expert Rev Clin Pharmacol. 2014; 1(1):39-47. DOI: 10.1586/17512433.1.1.39. View

18.

Goicoechea C, Sanchez E, Cano C, Jagerovic N, Martin M . Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally. Eur J Pharmacol. 2008; 595(1-3):22-9. DOI: 10.1016/j.ejphar.2008.07.052. View

19.

Jagerovic N, Cano C, Elguero J, Goya P, Callado L, Meana J . Long-acting fentanyl analogues: synthesis and pharmacology of N-(1-phenylpyrazolyl)-N-(1-phenylalkyl-4-piperidyl)propanamides. Bioorg Med Chem. 2002; 10(3):817-27. DOI: 10.1016/s0968-0896(01)00345-5. View

20.

Subramanian G, Paterlini M, Portoghese P, Ferguson D . Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor. J Med Chem. 2000; 43(3):381-91. DOI: 10.1021/jm9903702. View